Oncocyte reported raising $10.2 Million in an initial SEC Form D filing, from an offering of $10.2 Million
Round Type
Venture
IrvineBiotechnologyHealth CareGeneticsHealth DiagnosticsWho else raised in Genetics and Health Diagnostics around the same time
Companies in the same sectors as Insight Molecular Diagnostics Inc. that raised within 45 days of this round, from Fundz verified event records.
- Cambrian Bioworks raised $1.4M (Seed) on August 28, 2024.
- Ligence raised $3.2M (Seed) on November 13, 2024.
- Phlox Therapeutics raised $2M (Seed) on November 13, 2024.
- Quantune raised $14M (Seed) on November 12, 2024.
- MintNeuro raised $1.3M (Seed) on November 12, 2024.
- myBiometry raised $5M (Seed) on November 12, 2024.
Who to call at Insight Molecular Diagnostics Inc., and when
A new round usually means Insight Molecular Diagnostics Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Insight Molecular Diagnostics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Insight Molecular Diagnostics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Insight Molecular Diagnostics Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Insight Molecular Diagnostics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Insight Molecular Diagnostics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.